Articles for AstraZeneca (LSE: AZN)

Is now the time to buy this battered Footsie pharma stock?

Royston Wild looks at a troubled FTSE 100 (INDEXFTSE: UKX) stock and asks: could a share price turnaround be just around the corner? More »

AstraZeneca plc isn’t the only dividend stock I’d hold for the next decade

Roland Head explains why AstraZeneca plc (LON:AZN) could be a smart long-term buy. More »

Why I’d buy AstraZeneca plc and Taylor Wimpey plc today

Harvey Jones reckons AstraZeneca plc (LON: AZN) and Taylor Wimpey plc (LON: TW) are two of the most tempting plays on the FTSE 100. More »

Should you invest in AstraZeneca plc right now?

Could AstraZeneca plc (LON: AZN) help you invest your way to a fortune? More »

AstraZeneca plc isn’t the only way to play the world’s ageing population

AstraZeneca plc (LON: AZN) may have long-term potential, but could this 'niche' healthcare stock be a better way to play the world's ageing population?... More »

Why AstraZeneca plc shares could be the buy of the decade

AstraZeneca plc's (LON:AZN) share price could double in five years, says G A Chester. More »

AstraZeneca plc isn’t the only high-growth stock I’d buy today

This stock could deliver high returns alongside AstraZeneca plc (LON: AZN). More »

Why I’d buy Neil Woodford’s favourite dividend stock AstraZeneca plc in 2018

2018 could be the year that AstraZeneca plc's (LON: AZN) turnaround finally starts to take hold. More »

A Neil Woodford recovery stock I’d buy alongside AstraZeneca plc

Bolstering the risk of smaller-cap stocks by combining them with giants like AstraZeneca plc (LON: AZN) could be a winning strategy. More »

AstraZeneca plc isn’t the only pharma stock I’d buy today

Royston Wild explains why AstraZeneca plc (LON: AZN) could make you a fortune. More »

Why I’d buy FTSE 100 star Legal & General Group plc as profits set to hit record high

Roland Head explains why Legal & General Group plc (LON:LGEN) is one of his top FTSE 100 (INDEXFTSE:UKX) picks. More »

Why I’d sell this FTSE 250 flop and buy AstraZeneca plc instead

G A Chester sees a much stronger investment case for AstraZeneca plc (LON:AZN) than this FTSE 250 (INDEXFTSE:MCX) stock. More »

Is AstraZeneca plc a strong buy after Q3 results?

Is AstraZeneca plc (LON: AZN) still on course for a recovery? More »

Why I’d buy AstraZeneca plc over this soaring growth stock

Harvey Jones says AstraZeneca plc (LON: AZN) could hit new peaks and put this biotechnology upstart in its place. More »

This FTSE 100 growth stock could be a better buy than AstraZeneca plc

AstraZeneca plc (LON: AZN) is a popular healthcare stock among UK investors. But is this FTSE 100 (INDEXFTSE:UKX) joint replacement specialist a better buy?... More »

Why I’d buy this FTSE 250 stock alongside AstraZeneca plc

I think AstraZeneca plc (LON: AZN) pairs well with this FTSE 250 (INDEXFTSE: MCX) player. More »

Why I see more upside ahead for AstraZeneca plc

I believe that AstraZeneca plc's (LON: AZN) growth is only just getting started and there's still plenty of potential for investors. More »

Why I’d buy AstraZeneca plc for fat dividends and pipeline potential

The expiry of blockbuster patents has led some to doubt AstraZeneca plc (LON: AZN), but one Fool believes the company can innovate its way... More »

One growth stock I’d buy ahead of Astrazeneca plc

If dividends aren't a priority, Paul Summers think this top growth stock might be a better bet than Astrazeneca plc (LON:AZN). More »

AstraZeneca plc isn’t the only pharma star that could make you rich

AstraZeneca plc (LON: AZN) isn't the only pharma giant that could make you rich. Here Royston Wild looks at another drugs star with brilliant... More »